Valuation: Coral Laboratories Limited

Market Cap 132.38Cr 1.37Cr 1.2Cr 1.11Cr 1.02Cr 1.93Cr 1.97Cr 13Cr 5.21Cr 65Cr 5.16Cr 5.05Cr 223.2Cr P/E 2024
8.4x
P/E 2025 10.4x
Enterprise Value 104.99Cr 1.09Cr 95.28L 87.92L 81.04L 1.53Cr 1.56Cr 11Cr 4.13Cr 51Cr 4.09Cr 4Cr 177.02Cr EV / Sales 2024
1.25x
EV / Sales 2025 1.94x
Free-Float
19.98%
Yield 2024
0.54%
Yield 2025 0.21%
1 day-1.16%
1 week-0.63%
Current month-3.58%
1 month+19.18%
3 months+38.50%
6 months+33.56%
Current year+35.90%
1 week 580
Extreme 580
615
1 month 568.95
Extreme 568.95
659
Current year 360
Extreme 360
659
1 year 360
Extreme 360
659
3 years 244.5
Extreme 244.5
999
5 years 217
Extreme 217
999
10 years 81.2
Extreme 81.2
1,190
Manager TitleAgeSince
Director of Finance/CFO 49 26/05/2017
Director TitleAgeSince
Director/Board Member 45 26/05/2017
Director/Board Member 49 26/05/2017
Director/Board Member 40 28/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%-0.63%+0.72%+138.36% 2.21Cr
+0.85%-0.80%+52.79%+161.33% 1,05100Cr
+1.23%-1.53%+54.58%+59.08% 61TCr
+0.04%+2.58%+34.47%+86.33% 45TCr
+0.78%-0.71%+29.28%+24.10% 33TCr
+1.41%+0.58%+35.44%+40.67% 28TCr
-0.27%-1.87%+22.34%+22.51% 26TCr
-1.76%+2.37%-20.43%-38.00% 22TCr
-1.42%+0.80%+24.27%+57.50% 20TCr
-1.48%+3.43%+24.08%+71.67% 17TCr
Average -0.18%+0.42%+25.75%+62.35% 35.75TCr
Weighted average by Cap. +0.37%+0.02%+37.51%+79.63%

Financials

2024 2025
Net sales 84Cr 86.87L 75.92L 70.06L 64.57L 1.22Cr 1.24Cr 8.37Cr 3.29Cr 41Cr 3.26Cr 3.19Cr 141.05Cr 115.01Cr 1.19Cr 1.04Cr 96.3L 88.77L 1.67Cr 1.71Cr 12Cr 4.53Cr 56Cr 4.48Cr 4.39Cr 193.9Cr
Net income 16Cr 16.4L 14.33L 13.22L 12.19L 22.97L 23.48L 1.58Cr 62.16L 7.73Cr 61.57L 60.22L 27Cr 24Cr 25.08L 21.92L 20.23L 18.64L 35.14L 35.92L 2.42Cr 95.09L 12Cr 94.2L 92.13L 41Cr
Net Debt -28Cr -28.85L -25.22L -23.27L -21.45L -40.42L -41.32L -2.78Cr -1.09Cr -14Cr -1.08Cr -1.06Cr -47Cr -27Cr -28.44L -24.85L -22.94L -21.14L -39.85L -40.73L -2.74Cr -1.08Cr -13Cr -1.07Cr -1.04Cr -46Cr
Logo Coral Laboratories Limited
Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.
Employees
197
Date Price Change Volume
17/26/17 ₹595.90 -1.16% 123
16/26/16 ₹602.90 +1.63% 494
15/26/15 ₹593.25 -2.43% 511
14/26/14 ₹608.00 +0.56% 159
13/26/13 ₹604.60 +0.82% 964
  1. Stock Market
  2. Stocks
  3. CORALAB6 Stock